Faculty profile

Adil Adatia

Back to faculty

Assistant ProfessorMedicine DeptUniversity of Alberta

Adil Adatia

Assistant Professor

Medicine Dept

Faculty of Medicine & Dentistry

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
28 publications in the last five years, latest in 2026.
Senior (last) author on 11 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

205

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Alberta profile.

Latest papers

The International/Canadian hereditary angioedema guideline
Allergy, Asthma & Clinical Immunology · 2026
Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
Open-label phase 1b/2 trial of navenibart, a long-acting plasma kallikrein inhibitor for hereditary angioedema.
The Journal of allergy and clinical immunology · 2026

All 29 publications

Latest funding

Understanding Pulmonary Neuroendocrine Cells as Allergen Sensors and Immune Modulators
CIHR · 2024 · Co-investigator
$918,000

All 1 grants and awards

29 publications.

The International/Canadian hereditary angioedema guideline

Betschel S, Binkley K, Borici-Mazi R, Chapdelaine H, Hébert J, Kanani A, Keith PK, Lacuesta G, Waserman S, Yang W

Allergy, Asthma & Clinical Immunology20265 citationsOpen Access

DOI: 10.1186/s13223-025-00999-8

Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma.

Marriott H, Adatia A, Moitra S, Lacy P

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2026Open Access

DOI: 10.1111/cea.70294 PMID: 41896176

Open-label phase 1b/2 trial of navenibart, a long-acting plasma kallikrein inhibitor for hereditary angioedema.

Banerji A, Craig T, Sitz K, Li HH, Lumry W, Adatia A, Yang W, Jacobs JS, Tachdjian R, Soong W, Manning M, Wedner J, Savic S, Manson A, Valerieva A, Gunsior M, Mugundu G, Cohen T, Bernard K, VanEenwyk C, Joseph K, Best JM, Morabito C, Riedl MA

The Journal of allergy and clinical immunology2026

DOI: 10.1016/j.jaci.2026.02.034 PMID: 41794053

[Not Available].

L Zuraw B, Bork K, Bouillet L, C Christiansen S, Farkas H, E Germenis A, S Grumach A, Kaplan A, López-Lera A, Magerl M, A Riedl M, Adatia A, Banerji A, Betschel S, Boccon-Gibod I, Bova M, Balle Boysen H, Caballero T, Cancian M, J Castaldo A, M Cohn D, Corcoran D, Drouet C, Fukunaga A, Hide M, H Katelaris C, H Li P, Longhurst H, Peter J, Psarros F, Reshef A, Ritchie B, N Selva C, Zanichelli A, Maurer M

Arerugi = [Allergy]2026

DOI: 10.15036/arerugi.75.102 PMID: 41967933

The acuity of paediatric asthma in the emergency department worsened after the COVID-19 pandemic in Alberta, Canada.

Heibati B, Gill A, Moolji J, Adatia A

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2026Senior author

DOI: 10.1186/s13223-026-01045-x PMID: 42410629

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment.

Zuraw BL, Bork K, Bouillet L, Christiansen SC, Farkas H, Germenis AE, Grumach AS, Kaplan A, López-Lera A, Magerl M, Riedl MA, Adatia A, Banerji A, Betschel S, Boccon-Gibod I, Bova M, Boysen HB, Caballero T, Cancian M, Castaldo AJ, Cohn DM, Corcoran D, Drouet C, Fukunaga A, Hide M, Katelaris CH, Li PH, Longhurst H, Peter J, Psarros F, Reshef A, Ritchie B, Selva CN, Zanichelli A, Maurer M

Clinical reviews in allergy & immunology202560 citationsOpen Access

DOI: 10.1007/s12016-025-09027-4 PMID: 40053270

Unmet needs in hereditary angioedema: an international survey of physicians

Thomas Buttgereit, Felix Aulenbacher, Adil Adatia, Carolina Vera Ayala, Maryam Ali Al‐Nesf, Sabine Altrichter, Mohamed Abuzakouk, Mona Sulaiman Al-Ahmad, Ramzy Mohammed Ali, Alejandro Berardi, Isabelle Boccon-Gibod, Laurence Bouillet, Luisa Brussino, Marko Barešić, Paula Jane Busse, Stephen Betschel, Herberto José Chong‐Neto, Oscar Calderón Llosa, Timothy Craig, Anthony D. Dorr, Sérgio Duarte Dortas, Daria Fomina, Henriette Farkas, Jie Shen Fok, Anete Sevciovic Grumach, Jens Greve, Mar Guilarte, Margarida Gonçalo, Vesna Grivcheva‐Panovska, Michihiro Hide, et al. (61 authors)

Orphanet Journal of Rare Diseases202512 citationsOpen Access

DOI: 10.1186/s13023-025-03739-8 PMID: 40722187

Utilization of tetanus and diphtheria serology tests in Alberta, Canada: Patterns and implications

Jamil N. Kanji, Behzad Heibati, Nathan J. Zelyas, Hong Zhou, Gregory J. Tyrrell, Adil Adatia

PLoS ONE20252 citationsSenior authorOpen Access

DOI: 10.1371/journal.pone.0336690 PMID: 41270011

Health-related quality of life in hereditary angioedema patients treated with subcutaneous C1 inhibitor (C1-INH) therapy in Canada

Waserman S, Lacuesta G, Kanani AS, Sussman GL, Kim H, Chapdelaine H, Goubran Messiha HA, Kalicinsky C, Adatia A, Yap B

Allergy, Asthma & Clinical Immunology2025Open Access

DOI: 10.1186/s13223-025-00991-2

A sensitive and specific assay to characterize plasma kallikrein activity in plasma from patients with hereditary angioedema.

Lee DK, Ghannam A, Murugesan N, Vincent D, Dona M, Cohn DM, Adatia A, Smith MD, Audhya PK, Hampton SL, Feener EP

The World Allergy Organization journal2025

DOI: 10.1016/j.waojou.2025.101135 PMID: 41323125

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Adil Adatia

Research

Latest papers

Latest funding

The International/Canadian hereditary angioedema guideline

Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma.

Open-label phase 1b/2 trial of navenibart, a long-acting plasma kallikrein inhibitor for hereditary angioedema.

[Not Available].

The acuity of paediatric asthma in the emergency department worsened after the COVID-19 pandemic in Alberta, Canada.

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment.

Unmet needs in hereditary angioedema: an international survey of physicians

Utilization of tetanus and diphtheria serology tests in Alberta, Canada: Patterns and implications

Health-related quality of life in hereditary angioedema patients treated with subcutaneous C1 inhibitor (C1-INH) therapy in Canada

A sensitive and specific assay to characterize plasma kallikrein activity in plasma from patients with hereditary angioedema.

Understanding Pulmonary Neuroendocrine Cells as Allergen Sensors and Immune Modulators

Frequent collaborators

Bruce Ritchie

Jalal Moolji

Stephen Betschel

Susan Waserman

Harold Kim

Paige Lacy

Paul Keith

Subhabrata Moitra

Harissios Vliagoftis

Irvin Mayers

Nathan Zelyas

Karen Binkley

Lisa Fu

Erika Lee

Eric Leith

Valerie Palda

Brendan Halloran

Hugo Chapdelaine

Anne Hicks

Moshe Ben-Shoshan

Ann Clarke

Imran Satia

Gregory Tyrrell

Maria Ospina

Victoria Cook